Brain, Vol. 124, No. 10, 2000-2013,
October 2001
© 2001 Oxford University Press
Respiratory muscle strength and ventilatory failure in amyotrophic lateral sclerosis
1 Respiratory Muscle Laboratory, 2 Department of Palliative Care and Policy, Guys, Kings and St Thomas' School of Medicine, Kings College Hospital, London UK, and 3 Department of Neurology and the Kings' MND Care and Research Centre, Guys, Kings and St Thomas' School of Medicine and The Institute of Psychiatry, Kings College, London UK
Correspondence to:
Dr R. A. Lyall, Department of Respiratory Medicine and Allergy, Guys, Kings and St Thomas' School of Medicine, Denmark Hill Campus, Bessemer Road, London SE5 9PJ, UK E-mail: lyallrebecca{at}hotmail.com
Although ventilatory failure is the most common cause of death in amyotrophic lateral sclerosis (ALS) and measurement of respiratory muscle strength (RMS) has been shown to have prognostic value, no single test of strength can predict the presence of hypercapnia reliably. RMS was measured in 81 ALS patients to evaluate the relationship between tests of RMS and the presence of ventilatory failure, defined as a carbon dioxide tension
6 kPa. We studied the predictive value of vital capacity (VC), static inspiratory and expiratory mouth pressures (MIP, MEP), maximal sniff oesophageal (sniff Poes), transdiaphragmatic (sniff Pdi) and nasal (SNP) pressure, cough gastric (cough Pgas) pressure and transdiaphragmatic pressure after bilateral cervical magnetic phrenic nerve stimulation (CMS Pdi) to identify the risk of ventilatory failure in the whole group and in subgroups of patients with and without significant bulbar involvement. For patients without significant bulbar involvement, sniff Pdi had greatest predictive power [odds ratio (OR) 57] with specificity, sensitivity and positive and negative predictive values (PPV, NPV) of 87, 90, 74 and 95%, respectively Of the less invasive tests, per cent predicted SNP had greater overall predictive power (OR 25, specificity 85%, sensitivity 81%) than per cent predicted VC (9, 89%, 53%) and per cent predicted MIP (6, 83%, 55%). No test had significant predictive power for the presence of hypercapnia when used to measure RMS in a subgroup of patients with significant bulbar weakness. Thirty-five patients underwent polysomnography. CMS Pdi, sniff Pdi and per cent predicted SNP were significantly correlated with the apnoea/hypopnoea index (AHI) (P = 0.035, 0.042 and 0.026, respectively). The correlations between AHI and per cent predicted MIP and VC were less strong (both non-significant). In ALS patients without significant bulbar involvement, novel tests of RMS have greater predictive power than conventional tests to predict hypercapnia. In particular, the non-invasive SNP is more sensitive than VC and MIP, suggesting that it could usefully be included in tests of respiratory muscle strength in ALS and will be helpful in assessing the risk of ventilatory failure. In patients with significant bulbar involvement, tests of respiratory muscle strength do not predict hypercapnia. Sleep-disordered breathing is correlated with RMS and the novel tests of RMS having the strongest relationship with the degree of sleep disturbance.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
I. Yeldan, H N. Gurses, and H. Yuksel Comparison study of chest physiotherapy home training programmes on respiratory functions in patients with muscular dystrophy Clinical Rehabilitation, August 1, 2008; 22(8): 741 - 748. [Abstract] [PDF] |
||||
![]() |
N. Terzi, D. Orlikowski, C. Fermanian, M. Lejaille, L. Falaize, A. Louis, J-C. Raphael, B. Fauroux, and F. Lofaso Measuring inspiratory muscle strength in neuromuscular disease: one test or two? Eur. Respir. J., January 1, 2008; 31(1): 93 - 98. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Mitsumoto and J. G. Rabkin Palliative Care for Patients With Amyotrophic Lateral Sclerosis: "Prepare for the Worst and Hope for the Best" JAMA, July 11, 2007; 298(2): 207 - 216. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. G. Tankersley, C. Haenggeli, and J. D. Rothstein Respiratory impairment in a mouse model of amyotrophic lateral sclerosis J Appl Physiol, March 1, 2007; 102(3): 926 - 932. [Abstract] [Full Text] [PDF] |
||||
![]() |
J-W. Fitting Sniff nasal inspiratory pressure: simple or too simple? Eur. Respir. J., May 1, 2006; 27(5): 881 - 883. [Full Text] [PDF] |
||||
![]() |
N. Mustfa, E. Walsh, V. Bryant, R. A. Lyall, J. Addington-Hall, L. H. Goldstein, N. Donaldson, M. I. Polkey, J. Moxham, and P. N. Leigh The effect of noninvasive ventilation on ALS patients and their caregivers Neurology, April 25, 2006; 66(8): 1211 - 1217. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Eng Management guidelines for motor neurone disease patients on non-invasive ventilation at home Palliative Medicine, March 1, 2006; 20(2): 69 - 79. [Abstract] [PDF] |
||||
![]() |
C Moreau, D Devos, V Brunaud-Danel, L Defebvre, T Perez, A Destee, A B Tonnel, P. Lassalle, and N Just Paradoxical response of VEGF expression to hypoxia in CSF of patients with ALS J. Neurol. Neurosurg. Psychiatry, February 1, 2006; 77(2): 255 - 257. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Moreau, D. Devos, V. Brunaud-Danel, L. Defebvre, T. Perez, A. Destee, A. B. Tonnel, P. Lassalle, and N. Just Elevated IL-6 and TNF-{alpha} levels in patients with ALS: Inflammation or hypoxia? Neurology, December 27, 2005; 65(12): 1958 - 1960. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-W. Fitting Some Methodological Considerations Pertaining to Sniff Nasal Inspiratory Pressure (SNIP) Am. J. Respir. Crit. Care Med., October 1, 2005; 172(7): 932 - 933. [Full Text] [PDF] |
||||
![]() |
R. K. Morgan, S. McNally, M. Alexander, R. Conroy, O. Hardiman, and R. W. Costello Use of Sniff Nasal-Inspiratory Force to Predict Survival in Amyotrophic Lateral Sclerosis Am. J. Respir. Crit. Care Med., February 1, 2005; 171(3): 269 - 274. [Abstract] [Full Text] [PDF] |
||||
![]() |
W.D-C. Man, J. Moxham, and M.I. Polkey Magnetic stimulation for the measurement of respiratory and skeletal muscle function Eur. Respir. J., November 1, 2004; 24(5): 846 - 860. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. S. Shaw, M. A. Ampong, A. Rio, J. McClure, P. N. Leigh, and P. S. Sidhu Entristar Skin-Level Gastrostomy Tube: Primary Placement with Radiologic Guidance in Patients with Amyotrophic Lateral Sclerosis Radiology, November 1, 2004; 233(2): 392 - 399. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Simpson, J. Van Eyk, and S. Iscoe Respiratory muscle injury, fatigue and serum skeletal troponin I in rat J. Physiol., February 1, 2004; 554(3): 891 - 903. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. R. Bennett, H. M.A. Dunroy, D. R. Corfield, N. Hart, A. K. Simonds, M. I. Polkey, and M. J. Morrell Respiratory muscle activity during REM sleep in patients with diaphragm paralysis Neurology, January 13, 2004; 62(1): 134 - 137. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Wohlgemuth, E.L. van der Kooi, J.C. Hendriks, G.W. Padberg, and H.T. Folgering Face mask spirometry and respiratory pressures in normal subjects Eur. Respir. J., December 1, 2003; 22(6): 1001 - 1006. [Abstract] [Full Text] [PDF] |
||||
![]() |
N Hart, M I Polkey, T Sharshar, L Falaize, B Fauroux, J C Raphael, and F Lofaso Limitations of sniff nasal pressure in patients with severe neuromuscular weakness J. Neurol. Neurosurg. Psychiatry, December 1, 2003; 74(12): 1685 - 1687. [Abstract] [Full Text] [PDF] |
||||
![]() |
P N Leigh, S Abrahams, A Al-Chalabi, M-A Ampong, L H Goldstein, J Johnson, R Lyall, J Moxham, N Mustfa, A Rio, et al. The management of motor neurone disease J. Neurol. Neurosurg. Psychiatry, December 1, 2003; 74(90004): iv32 - 47. [Full Text] [PDF] |
||||
![]() |
N. Mustfa, M. Aiello, R. A. Lyall, D. Nikoletou, D. Olivieri, P. N. Leigh, A. C. Davidson, M. I. Polkey, and J. Moxham Cough augmentation in amyotrophic lateral sclerosis Neurology, November 11, 2003; 61(9): 1285 - 1287. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Laghi and M. J. Tobin Disorders of the Respiratory Muscles Am. J. Respir. Crit. Care Med., July 1, 2003; 168(1): 10 - 48. [Abstract] [Full Text] [PDF] |
||||
![]() |
R S Howard and R W Orrell Management of motor neurone disease Postgrad. Med. J., December 1, 2002; 78(926): 736 - 741. [Abstract] [Full Text] [PDF] |
||||
![]() |
K Talbot Motor neurone disease Postgrad. Med. J., September 1, 2002; 78(923): 513 - 519. [Abstract] [Full Text] [PDF] |
||||
![]() |
M D Bradley, R W Orrell, J Clarke, A C Davidson, A J Williams, D M Kullmann, N Hirsch, and R S Howard Outcome of ventilatory support for acute respiratory failure in motor neurone disease J. Neurol. Neurosurg. Psychiatry, June 1, 2002; 72(6): 752 - 756. [Abstract] [Full Text] [PDF] |
||||










